CAPITOL TIMES MEDIA

WASHINGTON — President Donald Trump’s choice to lead the Food and Drug Administration could force one of the nation’s most consequential abortion-policy battles back into the spotlight, as Dr. Heidi Overton prepares for a Senate confirmation fight with the federal government already conducting a safety review of mifepristone. Overton, a physician and senior White House domestic-policy official, was nominated by Trump on Aug. 19 to become the next FDA commissioner. If confirme

Rep. Alexandria Ocasio-Cortez is once again dominating the national conversation—this time not over legislation, but over a deeply personal decision that critics across conservative media say exposes the widening cultural and ideological gap between America’s political elite and ordinary families. Ocasio-Cortez, 36, disclosed in Instagram posts that she is undergoing the procedure to “feel more in control” of her life, while openly acknowledging that major life decisions are